RATIONALE: Acute lung injury (ALI) is a debilitating condition associated with severe skeletal muscle weakness that persists in humans long after lung injury has resolved. The molecular mechanisms underlying this condition are unknown. OBJECTIVES: To identify the muscle-specific molecular mechanisms responsible for muscle wasting in a mouse model of ALI. METHODS: Changes in skeletal muscle weight, fiber size, in vivo contractile performance, and expression of mRNAs and proteins encoding muscle atrophy-associated genes for muscle ring finger-1 (MuRF1) and atrogin1 were measured. Genetic inactivation of MuRF1 or electroporation-mediated transduction of miRNA-based short hairpin RNAs targeting either MuRF1 or atrogin1 were used to identify their role in ALI-associated skeletal muscle wasting. MEASUREMENTS AND MAIN RESULTS: Mice with ALI developed profound muscle atrophy and preferential loss of muscle contractile proteins associated with reduced muscle function in vivo. Although mRNA expression of the muscle-specific ubiquitin ligases, MuRF1 and atrogin1, was increased in ALI mice, only MuRF1 protein levels were up-regulated. Consistent with these changes, suppression of MuRF1 by genetic or biochemical approaches prevented muscle fiber atrophy, whereas suppression of atrogin1 expression was without effect. Despite resolution of lung injury and down-regulation of MuRF1 and atrogin1, force generation in ALI mice remained suppressed. CONCLUSIONS: These data show that MuRF1 is responsible for mediating muscle atrophy that occurs during the period of active lung injury in ALI mice and that, as in humans, skeletal muscle dysfunction persists despite resolution of lung injury.
RATIONALE: Acute lung injury (ALI) is a debilitating condition associated with severe skeletal muscle weakness that persists in humans long after lung injury has resolved. The molecular mechanisms underlying this condition are unknown. OBJECTIVES: To identify the muscle-specific molecular mechanisms responsible for muscle wasting in a mouse model of ALI. METHODS: Changes in skeletal muscle weight, fiber size, in vivo contractile performance, and expression of mRNAs and proteins encoding muscle atrophy-associated genes for muscle ring finger-1 (MuRF1) and atrogin1 were measured. Genetic inactivation of MuRF1 or electroporation-mediated transduction of miRNA-based short hairpin RNAs targeting either MuRF1 or atrogin1 were used to identify their role in ALI-associated skeletal muscle wasting. MEASUREMENTS AND MAIN RESULTS:Mice with ALI developed profound muscle atrophy and preferential loss of muscle contractile proteins associated with reduced muscle function in vivo. Although mRNA expression of the muscle-specific ubiquitin ligases, MuRF1 and atrogin1, was increased in ALI mice, only MuRF1 protein levels were up-regulated. Consistent with these changes, suppression of MuRF1 by genetic or biochemical approaches prevented muscle fiber atrophy, whereas suppression of atrogin1 expression was without effect. Despite resolution of lung injury and down-regulation of MuRF1 and atrogin1, force generation in ALI mice remained suppressed. CONCLUSIONS: These data show that MuRF1 is responsible for mediating muscle atrophy that occurs during the period of active lung injury in ALI mice and that, as in humans, skeletal muscle dysfunction persists despite resolution of lung injury.
Authors: S C Bodine; E Latres; S Baumhueter; V K Lai; L Nunez; B A Clarke; W T Poueymirou; F J Panaro; E Na; K Dharmarajan; Z Q Pan; D M Valenzuela; T M DeChiara; T N Stitt; G D Yancopoulos; D J Glass Journal: Science Date: 2001-10-25 Impact factor: 47.728
Authors: Margaret S Herridge; Catherine M Tansey; Andrea Matté; George Tomlinson; Natalia Diaz-Granados; Andrew Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Paul Kudlow; Deborah Cook; Arthur S Slutsky; Angela M Cheung Journal: N Engl J Med Date: 2011-04-07 Impact factor: 91.245
Authors: Sabah N A Hussain; Mahroo Mofarrahi; Ioanna Sigala; Ho Cheol Kim; Theodoros Vassilakopoulos; Francois Maltais; Ion Bellenis; Rakesh Chaturvedi; Stewart B Gottfried; Peter Metrakos; Gawiyou Danialou; Stefan Matecki; Samir Jaber; Basil J Petrof; Peter Goldberg Journal: Am J Respir Crit Care Med Date: 2010-07-16 Impact factor: 21.405
Authors: Tarek Sharshar; Sylvie Bastuji-Garin; Robert D Stevens; Marie-Christine Durand; Isabelle Malissin; Pablo Rodriguez; Charles Cerf; Hervé Outin; Bernard De Jonghe Journal: Crit Care Med Date: 2009-12 Impact factor: 7.598
Authors: Ashley J Smuder; W Bradley Nelson; Matthew B Hudson; Andreas N Kavazis; Scott K Powers Journal: Anesthesiology Date: 2014-07 Impact factor: 7.892
Authors: D Clark Files; Amro Ilaiwy; Traci L Parry; Kevin W Gibbs; Chun Liu; James R Bain; Osvaldo Delbono; Michael J Muehlbauer; Monte S Willis Journal: Metabolomics Date: 2016-07-26 Impact factor: 4.290
Authors: Esther Barreiro; Jacob I Sznajder; Gustavo A Nader; G R Scott Budinger Journal: Am J Respir Crit Care Med Date: 2015-03-15 Impact factor: 21.405
Authors: Ariel Jaitovich; Malik M H S Khan; Ria Itty; Hau C Chieng; Camille L Dumas; Pallavi Nadendla; John P Fantauzzi; Recai M Yucel; Paul J Feustel; Marc A Judson Journal: Chest Date: 2018-10-28 Impact factor: 9.410
Authors: D Clark Files; Chun Liu; Andrea Pereyra; Zhong-Min Wang; Neil R Aggarwal; Franco R D'Alessio; Brian T Garibaldi; Jason R Mock; Benjamin D Singer; Xin Feng; Raghunatha R Yammani; Tan Zhang; Amy L Lee; Sydney Philpott; Stephanie Lussier; Lina Purcell; Jeff Chou; Michael Seeds; Landon S King; Peter E Morris; Osvaldo Delbono Journal: Sci Transl Med Date: 2015-03-11 Impact factor: 17.956
Authors: Chia-Ling Wu; Evangeline W Cornwell; Robert W Jackman; Susan C Kandarian Journal: Am J Physiol Cell Physiol Date: 2014-02-19 Impact factor: 4.249